Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 024252/0650 | |
| Pages: | 8 |
| | Recorded: | 04/20/2010 | | |
| Attorney Dkt #: | 22006111-000042 |
| Conveyance: | SECURITY AGREEMENT |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/25/2007
|
Application #:
|
10256283
|
Filing Dt:
|
09/25/2002
|
|
Publication #:
|
|
Pub Dt:
|
03/25/2004
| | | | |
|
Title:
|
NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10776333
|
Filing Dt:
|
02/10/2004
|
|
Publication #:
|
|
Pub Dt:
|
08/11/2005
| | | | |
|
Title:
|
Controlled release formulations
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2013
|
Application #:
|
11689931
|
Filing Dt:
|
03/22/2007
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2007
| | | | |
|
Title:
|
Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11689939
|
Filing Dt:
|
03/22/2007
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2007
| | | | |
|
Title:
|
Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11839985
|
Filing Dt:
|
08/16/2007
|
|
Publication #:
|
|
Pub Dt:
|
02/21/2008
| | | | |
|
Title:
|
NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12049893
|
Filing Dt:
|
03/17/2008
|
|
Publication #:
|
|
Pub Dt:
|
09/11/2008
| | | | |
|
Title:
|
Controlled Release Formulations
|
|
|
Assignee
|
|
|
|
|
| 275 NORTH FIELD DRIVE |
| LAKE FOREST, ILLINOIS 60045 |
|
|
Correspondence name and address
|
| |
LISA PARKER GATES
|
| |
130 E. RANDOLPH DRIVE
|
| |
ONE PRUDENTIAL PLAZA, SUITE 3500
|
| |
CHICAGO, IL 60601
|
Search Results as of:
09/22/2024 06:03 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
